Ligand validation:2Y8Q

AMP: ADENOSINE MONOPHOSPHATE

AMP is a Ligand Of Interest in 2Y8Q designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2Y8Q_AMP_E_1328	89%	37%	0.097	0.975	0.9	1.54	1	2	0	0	100%	1
4EAI_AMP_C_401	92%	44%	0.085	0.975	0.88	1.26	-	2	0	0	100%	1
5ISO_AMP_F_403	91%	44%	0.099	0.985	0.91	1.26	1	4	0	0	100%	1
2V8Q_AMP_E_1327	91%	35%	0.092	0.977	1.04	1.51	1	3	1	0	100%	1
2YA3_AMP_E_1327	85%	38%	0.113	0.98	1.02	1.38	1	4	0	0	100%	1
8BIK_AMP_C_402	80%	56%	0.135	0.984	0.63	1.07	-	2	0	0	100%	1
3LOQ_AMP_A_271	100%	45%	0.039	0.987	0.82	1.3	-	2	2	0	100%	1
7SNB_AMP_A_303	100%	55%	0.045	0.993	0.75	0.98	-	1	0	0	100%	0.783
3FWZ_AMP_B_601	100%	32%	0.037	0.984	1.15	1.55	2	4	0	0	100%	1
4RDH_AMP_C_301	100%	23%	0.039	0.983	1.37	1.79	3	6	0	0	100%	1
3CLT_AMP_C_1262	100%	40%	0.046	0.987	0.91	1.4	1	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.